Final ID: Mo061
Watson Nathan, Kanthi Yogen, Secemsky Eric, Connors Jean, Barnes Geoffrey, Goldhaber Samuel, Weitz Jeffrey, Costenbader Karen, Piazza Gregory, Krumholz Harlan, Cushman Mary, Bukhari Syed, Bikdeli Behnood, Rashedi Sina, Weber Brittany, Anderson Christopher, Elkind Mitchell, Pfeferman Mariana, Ujueta Francisco, Zarghami Mehrdad
A First-In-Human Phase 1 Study of the Safety, Tolerability, and Pharmacodynamics of REGN7544, a Novel Natriuretic Peptide Receptor 1–Blocking Monoclonal AntibodyAhmed Mohsin, Morton Lori, Olenchock Benjamin, Herman Gary, Wynne Chris, Marin Ethan, Tuckwell Katie, Xu Meng, Cheng Xiping, Redington Emily, Koyani Bharatkumar, Mateo Katrina, Thakur Mazhar, Devalaraja-narashimha Kishor